| Antigen | 17-aa peptide from Human CLC7 (1); Designation (#CLC72-P, control/blocking peptide) conjugated to KLH; epitope location ~ N-terminal, Cytoplasmic domain |
| Form | Affinity purified IgG |
| Product Type | Primary Antibodies |
| SpCrossreactivity | The human CLC72-P control peptide is 93% conserved in mouse/rat CLC-7. No significant sequence homology is detected with other CLCs or other proteins. Antibody crossreactivity in various species is not established |
| SpeciesReactivity | Human |
| SugApplications | Most Antibodies are tested by ELISA and Western. Additional applications, such as IHC or IP may have been tested and will be listed in the product data sheets or published research papers using our products. Typically, antibodies are tested against the |
| SugNegativeControl | Non-immune Rabbit IgG Cat# 20009-1 |
| SugPositiveControl | Recombinant or naturally purified proteins or cells of tissues expressing the protein under study can be used as positive controls for Western or IHC. Please review the ?General Information? tan under Product overview section. Control or blocking peptid |
| SugSecAntibodies | http://4adi.com/commerce/ccc2480-secondary-antibodies-rabbit.htm |